Is there life after technetium: What is the potential for developing new broad-based radionuclides?

This publication has 23 references indexed in Scilit:

• Criteria for the Selection of Radionuclides for Targeting Nuclear Antigens for Cancer Radioimmunotherapy
  Cancer Biotherapy & Radiopharmaceuticals, 1996
• Current status of radioimmunotherapy
  Nuclear Medicine and Biology, 1994
• Selection of radionuclides for radioimmunotherapy
  Medical Physics, 1993
• The use of a new radiopharmaceutical, 97Ru-DISIDA, and of 99Tcm-sulphur colloid for the simultaneous evaluation of duodenogastric reflux and gastric emptying
  Nuclear Medicine Communications, 1992
• Review Radiolabelled monoclonal antibodies in oncology III. Radioimmunotherapy
  Nuclear Medicine Communications, 1991
• Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies
  Medical Physics, 1984
• Radiation absorbed dose estimates at the cellular level for some electron-emitting radionuclides for radioimmunotherapy
  The International Journal of Applied Radiation and Isotopes, 1984
• Uptake of ruthenium-labeled transferrin in healing wounds
  International Journal of Nuclear Medicine and Biology, 1983
• Technetium-99m: An historical perspective
  The International Journal of Applied Radiation and Isotopes, 1982
• Biological damage from the Auger effect, possible benefits
  Radiation and Environmental Biophysics, 1975